Related references
Note: Only part of the references are listed.Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas
Marco Rossi et al.
NEURO-ONCOLOGY (2021)
Effects of brain radiotherapy on cognitive performance in adult low-grade glioma patients: A systematic review
Christos Koutsarnakis et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management
Michael Back et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2019)
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas
Romain Appay et al.
NEURO-ONCOLOGY (2019)
Extent of resection and survival for oligodendroglioma: a US population-based study
Connor J. Kinslow et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma
Michael Back et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis
Maarten M. J. Wijnenga et al.
NEURO-ONCOLOGY (2018)
The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas
Toral Patel et al.
NEUROSURGERY (2018)
Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible?
Hugues Duffau
NEUROSURGICAL REVIEW (2018)
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
Biqi Zhang et al.
NEURO-ONCOLOGY (2017)
Response Assessment in Neuro-Oncology Clinical Trials
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma
M. Back et al.
RADIATION ONCOLOGY (2017)
Functional MRI for Surgery of Gliomas
Antonella Castellano et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2017)
Surgical resection versus watchful waiting in low-grade gliomas
A. S. Jakola et al.
ANNALS OF ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemoradiotherapy
Pierina Navarria et al.
BMC CANCER (2016)
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Maximizing safe resection of low- and high-grade glioma
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEUROSURGERY (2016)
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
Adriana Olar et al.
ACTA NEUROPATHOLOGICA (2015)
The role of surgery in the management of patients with diffuse low grade glioma A systematic review and evidence-based clinical practice guideline
Manish K. Aghi et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques
Caroline A. Racine et al.
NEUROSURGERY (2015)
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
J. Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas
Juan Martino et al.
ACTA NEUROCHIRURGICA (2013)
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients Clinical article
Tamara Ius et al.
JOURNAL OF NEUROSURGERY (2012)
Cost-Effectiveness Analysis of Amino Acid PET-Guided Surgery for Supratentorial High-Grade Gliomas
Alexander Heinzel et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Philippe Metellus et al.
ACTA NEUROPATHOLOGICA (2010)
Insular glioma resection: assessment of patient morbidity, survival, and tumor progression Clinical article
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2010)
PET for radiation treatment planning of brain tumours
Anca-L. Grosu et al.
RADIOTHERAPY AND ONCOLOGY (2010)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Share Paper
